Trade DBV Technologies SA - DBV CFD
Add to favourite- Summary
- Historical Data
Spread | 0.02 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.020029% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.002193% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 0.5 | ||||||||
Currency | EUR | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | France | ||||||||
Commission on trade | 0% |
Prev. Close | 0.5 |
Open | 0.5 |
1-Year Change | -68.75% |
Day's Range | 0.5 - 0.54 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Nov 21, 2024 | 0.50 | -0.01 | -1.96% | 0.51 | 0.51 | 0.50 |
Nov 20, 2024 | 0.52 | -0.01 | -1.89% | 0.53 | 0.53 | 0.51 |
Nov 19, 2024 | 0.53 | -0.02 | -3.64% | 0.55 | 0.57 | 0.52 |
Nov 18, 2024 | 0.55 | -0.03 | -5.17% | 0.58 | 0.59 | 0.54 |
Nov 15, 2024 | 0.59 | -0.02 | -3.28% | 0.61 | 0.62 | 0.58 |
Nov 14, 2024 | 0.61 | -0.03 | -4.69% | 0.64 | 0.65 | 0.60 |
Nov 13, 2024 | 0.65 | 0.00 | 0.00% | 0.65 | 0.66 | 0.64 |
Nov 12, 2024 | 0.66 | -0.02 | -2.94% | 0.68 | 0.70 | 0.64 |
Nov 11, 2024 | 0.66 | -0.03 | -4.35% | 0.69 | 0.71 | 0.66 |
Nov 8, 2024 | 0.69 | -0.01 | -1.43% | 0.70 | 0.71 | 0.68 |
Nov 7, 2024 | 0.71 | -0.01 | -1.39% | 0.72 | 0.73 | 0.67 |
Nov 6, 2024 | 0.76 | 0.01 | 1.33% | 0.75 | 0.78 | 0.75 |
Nov 5, 2024 | 0.76 | -0.02 | -2.56% | 0.78 | 0.80 | 0.73 |
Nov 4, 2024 | 0.76 | 0.01 | 1.33% | 0.75 | 0.80 | 0.74 |
Nov 1, 2024 | 0.76 | 0.00 | 0.00% | 0.76 | 0.77 | 0.74 |
Oct 31, 2024 | 0.74 | -0.01 | -1.33% | 0.75 | 0.79 | 0.73 |
Oct 30, 2024 | 0.76 | -0.03 | -3.80% | 0.79 | 0.79 | 0.73 |
Oct 29, 2024 | 0.77 | -0.01 | -1.28% | 0.78 | 0.80 | 0.77 |
Oct 28, 2024 | 0.79 | -0.04 | -4.82% | 0.83 | 0.85 | 0.79 |
Oct 25, 2024 | 0.80 | 0.00 | 0.00% | 0.80 | 0.85 | 0.79 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
DBV Technologies Company profile
About DBV Technologies SA
DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, DBV Technologies SA revenues decreased 49% to $5.7M. Net loss applicable to common stockholders decreased 39% to $98.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Research and Development decrease of 31% to $70.1M (expense), Restructuring decrease from $23M (expense) to $920K (income).
Industry: | Proprietary & Advanced Pharmaceuticals |
177-181 avenue Pierre Brossolette
MONTROUGE
ILE-DE-FRANCE 92120
FR
News
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
15:17, 18 November 2024Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com